Quantum Genomics Société Anonyme Balance Sheet Health
Financial Health criteria checks 3/6
Quantum Genomics Société Anonyme has a total shareholder equity of €1.6M and total debt of €2.9M, which brings its debt-to-equity ratio to 179.2%. Its total assets and total liabilities are €5.8M and €4.1M respectively.
Key information
179.2%
Debt to equity ratio
€2.91m
Debt
| Interest coverage ratio | n/a |
| Cash | €2.76m |
| Equity | €1.62m |
| Total liabilities | €4.13m |
| Total assets | €5.76m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2QG's short term assets (€5.6M) exceed its short term liabilities (€1.2M).
Long Term Liabilities: 2QG's short term assets (€5.6M) exceed its long term liabilities (€2.9M).
Debt to Equity History and Analysis
Debt Level: 2QG's net debt to equity ratio (9.3%) is considered satisfactory.
Reducing Debt: 2QG's debt to equity ratio has increased from 0.04% to 179.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2QG has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 2QG has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.8% each year